Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,24118,260 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Role of Transcription Factor ADP-ribosylation in Breast Cancer Biology
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2026

Project Summary/Abstract The molecular heterogeneity of cancers poses a major hurdle for treatment and drug discovery efforts. Previous studies have addressed this challenge by cha...

$4.03M
USD
Completed NON-SBIR/STTR RPGS
Joint receptor and protein expression immunophenotyping through split-pool barcoding
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2024

Single-cell immune repertoire sequencing can provide invaluable information about the response of the adaptive immune system to disease and therapy. However, existing approaches fo...

$4.01M
USD
Completed TRAINING, INDIVIDUAL
Lipid metabolism as a therapeutic vulnerability in BET inhibitor-resistant medulloblastoma
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2024

Project Summary/Abstract MYC-driven medulloblastomas are a particularly devastating group of pediatric brain tumors that exhibit resistance and continued progression despite standa...

$674.8K
USD
Completed TRAINING, INDIVIDUAL
The role of CaMKK2 in tumor-infiltrating natural killer cells
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2023

Abstract: Calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) is an important regulator of cellular metabolism. Though classically associated with neurons and macrophages...

$388.4K
USD
Completed NON-SBIR/STTR RPGS
The selective advantage of mismatch repair loss in colonic stem cells
NATIONAL CANCER INSTITUTE University of Connecticut Sch of Med/Dnt United States 2021 – 2026

Project Summary Lynch syndrome (LS) is a hereditary disease that predisposes patients to colorectal, endometrial, ovarian and other cancers. LS is caused by inherited mutations in...

$4.72M
USD
Completed NON-SBIR/STTR RPGS
Improving efficacy of radioiodine treatment of thyroid cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Patients with advanced thyroid cancer are frequently refractory to radioiodine (RAI) therapy. Oncoproteins that constitutively activate MAPK signaling suppress expression of genes...

$4.62M
USD
Completed TRAINING, INSTITUTIONAL
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2023

Rutgers Cancer Institute of New Jersey (RCINJ) provides an outstanding environment for training in basic, clinical, behavioral or population-based cancer research and brings togeth...

$3.15M
USD
Completed NON-SBIR/STTR RPGS
SMARCB1 regulated SWI/SNF complex function in Malignant Rhabdoid Tumors
NATIONAL CANCER INSTITUTE Dartmouth College United States 2021 – 2026

PROJECT SUMMARY A research program will be undertaken to study SMARCB1-regulated SWI/SNF complex function in malignant rhabdoid tumors. Over the past few years, major cancer genome...

$3.75M
USD
Completed NON-SBIR/STTR RPGS
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY Recent whole-exome sequencing studies in human cancer and neurodevelopmental disorders have unmasked frequent mutations in genes encoding chromatin regulatory prote...

$6.77M
USD
Completed NON-SBIR/STTR RPGS
Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation
NATIONAL CANCER INSTITUTE Jackson Laboratory United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Metastatic disease remains the major cause of cancer-related death. Among the vital organs to which solid tumors metastasize, the lung is one of the most c...

$4.75M
USD
Completed NON-SBIR/STTR RPGS
Gain-of-function mutant p53 and metabolic reprogramming in colorectal cancer
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2023

Tumor suppressor p53 plays a central role in tumor prevention. p53 is frequently mutated in human cancer, including colorectal cancer (CRC). Many mutant p53 (mutp53) proteins not o...

$4.5M
USD
Completed NON-SBIR/STTR RPGS
New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions
NATIONAL CANCER INSTITUTE George Mason University United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT: New molecular modalities to target sites of protein-protein interaction with high affinity and specificity are desperately needed in cancer treatment. Blo...

$1.62M
USD
Active NON-SBIR/STTR RPGS
Novel Optimization Methods and Treatment Planning System for Clinically-Deliverable Truly-Hybrid Proton-Photon Radiotherapy
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2021 – 2026

Project Summary Radiotherapy (RT) aims to deliver tumoricidal dose to clinical target volume (CTV) while sparing organs at risk (OAR), for which proton and photon beams are natural...

$3.55M
USD
Completed OTHER RESEARCH-RELATED
Does obesity influence protein quality control in endometrial cancer?
NATIONAL CANCER INSTITUTE Michigan State University United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT Research Project: Excess body weight is a contributing factor in up to 20% of all cancer deaths in women. In particular, endometrial cancer (EC) incidence...

$1.18M
USD
Completed NON-SBIR/STTR RPGS
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
NATIONAL CANCER INSTITUTE University of Louisiana At Monroe United States 2021 – 2026

Project Summary: The long-term objective of this research project is to understand the role of dimerization in extracellular domains (ECD) of epidermal growth factor receptors (EGF...

$3.23M
USD
Completed NON-SBIR/STTR RPGS
Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Caring for an allogeneic hematopoietic stem cell transplant (HCT) patient is a significant responsibility, involving a commitment to be available 24/7 up t...

$5.91M
USD
Completed NON-SBIR/STTR RPGS
Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2026

ABSTRACT Clonal hematopoesis (CH) defined as the presence of acquired mutations detectable in peripheral blood of normal healthy individuals without hematologic malignancies (HM) h...

$6.65M
USD
Completed TRAINING, INDIVIDUAL
Metabolic Contributions of Individual Cellular Compartments to the Diversity of the Tumor Microenvironment in Renal Cell Carcinoma
NATIONAL CANCER INSTITUTE Vanderbilt University United States 2021 – 2024

PROJECT SUMMARY Deregulating cellular energetics and avoiding immune destruction are considered hallmarks of cancer. Stimulating anti-tumor immunity is now a chief goal of cancer t...

$495.1K
USD
Completed NON-SBIR/STTR RPGS
CRL3KEAP1 complex licenses genotoxic stress-induced tumor cell death
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT This application is responsive to PA-17-449: The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21). In general, geno...

$1.97M
USD
Completed NON-SBIR/STTR RPGS
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

Invasive lobular breast cancer (ILC) is the second most common histological subtype of breast cancer after the more common invasive ductal breast cancer (IDC). In 2020, ILC will af...

$5.68M
USD